Eswatini vs Niger: Cause of death, by non-communicable diseases, ages 5-14
Eswatini
16.3%
in 2021
Niger
17.4%
in 2021
Eswatini rank
169th
Niger rank
166th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Eswatini
- Niger
How they compare
Niger currently reports 17.4% against 16.3% in Eswatini, a difference of 1.1%.
That makes Niger's figure about 1.1 times Eswatini's.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Niger ahead.
Eswatini ranks 169th and Niger ranks 166th of 185 countries.
Niger has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eswatini | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.5% | 13.7% | 8.2% | Niger |
| 2010s | 8.9% | 16.1% | 7.2% | Niger |
| 2020s | 16.7% | 17.2% | 0.5% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Eswatini or Niger?
- Niger, at 17.4% against 16.3% in Eswatini as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Eswatini and Niger?
- 1.1%, with Niger ahead.
- How many years of comparable data are there for Eswatini and Niger?
- 6 years are reported by both, from 2000 to 2021.
- How do Eswatini and Niger rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Eswatini ranks 169th and Niger ranks 166th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.